SIEBERT JOHN M has filed 8 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 3886 shares of SUPERNUS PHARMACEUTICALS, INC. ($SUPN) on February 23, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | A | Common Stock | 3886 | $0.00 | 87,943.0000 | 55,506,828 | 4.62% | 0.01% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | D | Restricted Stock Unit | 3886 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.01% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | A | Director Stock Option (Right to Buy) | 8252 | $0.00 | 8,252.0000 | 55,506,828 | 9999.99% | 0.01% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | A | Restricted Stock Units | 5369 | $0.00 | 5,369.0000 | 55,506,828 | 9999.99% | 0.01% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | A | Director Stock Option (Right to Buy) | 6293 | $0.00 | 6,293.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | A | Restricted Stock Units | 3886 | $0.00 | 3,886.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | A | Common Stock | 3882 | $0.00 | 84,057.0000 | 61,679,800 | 4.84% | 0.01% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | SIEBERT JOHN M | Director | D | Restricted Stock Units | 3882 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.01% |